Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

DarioHealth (DRIO) Gross Margin (2016 - 2025)

DarioHealth filings provide 12 years of Gross Margin readings, the most recent being 53.6% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 166.0% to 53.6% in Q4 2025 year-over-year; TTM through Dec 2025 was 56.64%, a 758.0% increase, with the full-year FY2025 number at 56.64%, up 758.0% from a year prior.
  • Gross Margin hit 53.6% in Q4 2025 for DarioHealth, down from 60.22% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 60.22% in Q3 2025 to a low of 17.81% in Q4 2022.
  • Median Gross Margin over the past 5 years was 37.97% (2023), compared with a mean of 33.98%.
  • Biggest five-year swings in Gross Margin: crashed -2690bps in 2022 and later soared 5161bps in 2024.
  • DarioHealth's Gross Margin stood at 9.09% in 2021, then tumbled by -296bps to 17.81% in 2022, then surged by 120bps to 3.65% in 2023, then soared by 1414bps to 55.26% in 2024, then dropped by -3bps to 53.6% in 2025.
  • The last three reported values for Gross Margin were 53.6% (Q4 2025), 60.22% (Q3 2025), and 55.21% (Q2 2025) per Business Quant data.